Australian Stocks With U.S. Exposure Could Be a 'Trump Trade' Bet -- Market Talk

Investors looking to bet on so-called "Trump trade" could look to overweight Australian stocks with high U.S. exposure, say Macquarie analysts in a note.

WSJJul 21 21:21 ET

UBS Adjusts ResMed Price Target to $210 From $195, Maintains Neutral Rating

ResMed (RMD) has an average outperform rating and a price target range of $21.64 to $264, according to analysts polled by Capital IQ.Price: 205.06, Change: +1.18, Percent Change: +0.58

MT NewswiresJul 19 09:45 ET

Express News | Resmed Inc : UBS Raises Target Price to $210 From $195

ReutersJul 19 08:56 ET

Do Weight Loss Drugs Pose a Threat to ResMed Shares?

ResMed Inc (ASX: RMD) shares have been under the spotlight recently after sliding from their previous highs of $33.10 apiece.

The Motley FoolJul 18 23:18 ET

VARON Enters CPAP and BiPAP Machine Market With Feature-Rich "Sunny Grand" Series

SEATTLE, July 18, 2024 /PRNewswire/ -- VARON, a leading provider of oxygen concentrator solutions, is thrilled to announce the launch of its new line of CPAP (continuous positive airway pressure)

PR NewswireJul 18 13:30 ET

Returns On Capital Are A Standout For ResMed (NYSE:RMD)

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an eye out for. In a perfect world, we'd like to see a company investing more

Simply Wall StJul 17 13:30 ET